SBIR funding by the NHLBI to Selexys results in the development of crizanlizumab. Selexys was founded in 2002 by Rodger (Rod) McEver, M.D., Richard Cummings, Ph.D., and Rick Alvarez, M.B.A....

Dear Glycoscientists:

The deadline for submission of poster abstracts to the 2018 conference on Sialic Acids has been extended to Friday March 30th. This biennial conference is being held May 10-14 in Banff, Canada.

For details on the Sialoglyco2018 conference, see ...

October 3-6, 2018 in Dubrovnik, Croatia

www.glycocom.net  (website still in development, check back soon!)

Dear Glycoscientists,

On behalf of the members of the Scientific Advisory Board, I invite you to attend the next biennial conference on the Biology, Biochemistry and Chemistry of Sialic Acids, Sialoglyco2018. The meeting will be held May 10-14, 2018 in Banff, Alberta, which is located in the Canadian...